{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:47Z","timestamp":1792807547223,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250960-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Telestroke has the potential to revolutionize acute stroke treatment by improving access to optimal stroke care, including time-sensitive care such as thrombolysis. However, it is unclear how treatment times and stroke outcomes compare between patients evaluated and not evaluated by telestroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250960-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the association between telestroke use and acute stroke treatment times and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250960-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cohort study included patients with acute ischemic stroke aged 18 years or older presenting to 42 Paul Coverdell Michigan Stroke Registry hospitals from January 1, 2022, to December 31, 2023. All patients were potentially eligible for thrombolysis (ie, presented \u22644 hours of last known well, no contraindications to thrombolysis documented).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250960-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Telestroke (vs nontelestroke) encounter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250960-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcomes were receipt of thrombolysis and door-to-needle (DTN) time as a continuous variable and a categorical variable (\u226460 vs &amp;amp;gt;60 minutes). Secondary outcomes included discharge ambulatory status, discharge destination, and door-in-door-out (DIDO) time in transferred patients. Multivariable hierarchical models evaluated associations between telestroke (vs nontelestroke) activation and outcomes, sequentially adjusting for demographics, medical history, presentation or arrival, and hospital characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250960-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 3036 patients with acute ischemic stroke potentially eligible for thrombolysis (mean [SD] age, 69.7 [14.5] years; 1563 male [51.5%]), 785 (25.9%) were evaluated using telestroke and 2251 (74.1%) without telestroke. A total of 1673 patients (55.1%) were treated with thrombolysis. In the fully adjusted models, patients evaluated by telestroke had a significantly higher odds of receiving thrombolysis (adjusted odds ratio, 1.61; 95% CI, 1.17-2.23) but longer DTN times (6.55 minutes longer; 95% CI, 2.12-10.97 minutes longer) and lower odds of meeting a guideline-concordant DTN time within 60 minutes (adjusted odds ratio, 0.56; 95% CI, 0.39-0.81) compared with those not evaluated by telestroke. Among 255 patients who underwent interhospital transfer, 207 (81.2%) received thrombolysis, and patients with telestroke had significantly longer DIDO times (46.90 minutes longer, 95% CI, 1.08-92.72 minutes longer).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250960-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of patients with acute ischemic stroke potentially eligible for thrombolysis, those evaluated by telestroke had a 61% higher odds of receiving thrombolysis but a 44% lower odds of meeting guideline-concordant DTN times within 60 minutes and prolonged DIDO times compared with those not evaluated by telestroke. Future research should investigate modifiable factors that contribute to treatment delays in patients with ischemic stroke evaluated via telestroke.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.34275","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:30:37Z","timestamp":1758900637000},"page":"e2534275","source":"Crossref","is-referenced-by-count":13,"title":["Telestroke and Timely Treatment and Outcomes in Patients With Acute Ischemic Stroke"],"prefix":"10.1001","volume":"8","author":[{"given":"Brian","family":"Stamm","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Geriatric Research Education and Clinical Center, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael T.","family":"Whitney","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Royan","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Emergency Medicine, University of Michigan, Ann Arbor"},{"name":"Assistant Editor, JAMA Network Open"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne V.","family":"Nickles","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Ferber","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ling","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Chhabra","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney A.","family":"Hayward","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Center for Brain and Mind Health, Departments of Neurology and Neurosurgery, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"23","key":"zoi250960r1","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1001\/jama.2013.6959","article-title":"Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.","volume":"309","author":"Saver","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"zoi250960r2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis.","volume":"316","author":"Saver","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"zoi250960r3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.STR.0000196957.55928.ab","article-title":"Time is brain\u2013quantified.","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"issue":"10","key":"zoi250960r4","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1161\/STROKEAHA.111.621342","article-title":"Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association\/American Stroke Association\u2019s Target: Stroke initiative.","volume":"42","author":"Fonarow","year":"2011","journal-title":"Stroke"},{"issue":"12","key":"zoi250960r5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007150","article-title":"Target: Stroke was associated with faster intravenous thrombolysis and improved one-year outcomes for acute ischemic stroke in Medicare beneficiaries.","volume":"13","author":"Man","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"16","key":"zoi250960r6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/jama.2014.3203","article-title":"Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.","volume":"311","author":"Fonarow","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"zoi250960r8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1377\/hlthaff.2018.05089","article-title":"Expansion of telestroke services improves quality of care provided in super rural areas.","volume":"37","author":"Zhang","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"zoi250960r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106171","article-title":"Considerations for the implementation of a telestroke network: a systematic review.","volume":"31","author":"Tumma","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"zoi250960r10","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1161\/STR.0000000000000114","article-title":"Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"48","author":"Wechsler","year":"2017","journal-title":"Stroke"},{"issue":"11","key":"zoi250960r11","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1161\/STROKEAHA.111.625046","article-title":"Telestroke-guided intravenous tissue-type plasminogen activator treatment achieves a similar clinical outcome as thrombolysis at a comprehensive stroke center.","volume":"42","author":"Zaidi","year":"2011","journal-title":"Stroke"},{"issue":"11","key":"zoi250960r12","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.024","article-title":"Comparison of stroke outcomes of hub and spoke hospital treated patients in Mayo Clinic telestroke program.","volume":"27","author":"Demaerschalk","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"zoi250960r13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/tmj.2017.0067","article-title":"Door to needle time over telestroke-a comprehensive stroke center experience.","volume":"24","author":"Al Kasab","year":"2018","journal-title":"Telemed J E Health"},{"issue":"4","key":"zoi250960r14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1941874417704753","article-title":"The door to needle time metric can be achieved via telestroke.","volume":"7","author":"Asaithambi","year":"2017","journal-title":"Neurohospitalist"},{"issue":"1","key":"zoi250960r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108141","article-title":"Target door-to-needle time in acute stroke treatment via telemedicine versus in-person evaluation in a rural setting of the Midwest: a retrospective cohort study.","volume":"34","author":"Loggini","year":"2025","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7624","key":"zoi250960r17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"3","key":"zoi250960r18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/STROKEAHA.117.019341","article-title":"Predictors of thrombolysis administration in mild stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.","volume":"49","author":"Asdaghi","year":"2018","journal-title":"Stroke"},{"issue":"3","key":"zoi250960r19","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"zoi250960r20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12911-019-1010-x","article-title":"Assessing stroke severity using electronic health record data: a machine learning approach.","volume":"20","author":"Kogan","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"zoi250960r21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/CIRCOUTCOMES.112.965210","article-title":"Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.","volume":"5","author":"Lin","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"zoi250960r22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/jama.2019.8286","article-title":"Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice.","volume":"322","author":"Jahan","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"zoi250960r24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003359","article-title":"Rates, characteristics, and outcomes of patients transferred to specialized stroke centers for advanced care.","volume":"11","author":"Ali","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"zoi250960r27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jama.2023.12739","article-title":"Door-in-door-out times for interhospital transfer of patients with stroke.","volume":"330","author":"Stamm","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"zoi250960r28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1089\/tmj.2018.0133","article-title":"Evaluation of the experience of spoke hospitals in an academic telestroke network.","volume":"25","author":"Gadhia","year":"2019","journal-title":"Telemed J E Health"},{"issue":"5","key":"zoi250960r30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jamaneurol.2021.0023","article-title":"Reperfusion treatment and stroke outcomes in hospitals with telestroke capacity.","volume":"78","author":"Wilcock","year":"2021","journal-title":"JAMA Neurol"},{"issue":"10029","key":"zoi250960r31","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"zoi250960r32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000177","article-title":"Predicting 90-day modified Rankin Scale score with discharge information in acute ischaemic stroke patients following treatment.","volume":"3","author":"ElHabr","year":"2021","journal-title":"BMJ Neurol Open"},{"key":"zoi250960r7","unstructured":"American Heart Association. Phase III Target: Stroke. American Stroke Association. Accessed July 14, 2025. https:\/\/www.stroke.org\/-\/media\/files\/professional\/quality-improvement\/target-stroke\/target-stroke-phase-iii\/aha-qi-target-stroke-phase-3-brochure.pdf"},{"key":"zoi250960r16","unstructured":"Paul Coverdell National Acute Stroke Program. Centers for Disease Control and Prevention. Accessed August 23, 2025. https:\/\/www.cdc.gov\/coverdell\/?CDC_AAref_Val"},{"key":"zoi250960r23","unstructured":"Stroke certification. Joint Commission. Accessed June 22, 2025. https:\/\/www.jointcommission.org\/resources\/news-and-multimedia\/fact-sheets\/facts-about-stroke-certification\/"},{"key":"zoi250960r25","unstructured":"Specifications manual for Joint Commission national quality measures (v2024A1). Joint Commission. 2024. Accessed August 5, 2024. https:\/\/manual.jointcommission.org\/releases\/TJC2024A1\/MIF0391.html"},{"key":"zoi250960r26","unstructured":"Door-in-door out best practice strategies. American Heart Association. Accessed December 6, 2024. https:\/\/www.heart.org\/-\/media\/Files\/Professional\/Quality-Improvement\/Get-With-the-Guidelines\/Get-With-The-Guidelines-Stroke\/Uploads-DIDO-08122021\/DIDO-Best-Practices_F1.pdf"},{"key":"zoi250960r29","unstructured":"Michigan Stroke Program. Michigan Department of Health & Human Services. Accessed November 20, 2024. https:\/\/www.michigan.gov\/mdhhs\/keep-mi-healthy\/communicablediseases\/epidemiology\/chronicepi\/stroke"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839374\/stamm_2025_oi_250960_1758301008.68298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:30:39Z","timestamp":1758900639000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.34275","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}